Nanotechnology and nanomedicine in cardiovascular therapy - Biomaterials and Devices for the Circulatory System - page 259

KONG, W. H., LEE, W. J., CUI, Z. Y., BAE, K. H., PARK, T. G., KIM, J. H., PARK, K. & SEO, S. W.
(2007) Nanoparticulate carrier containing water-insoluble iodinated oil as a mul-
tifunctional contrast agent for computed tomography imaging. Biomaterials , 28 ,
5555-61.
KOROSOGLOU, G., SHAH, S., VONKEN, E. J., GILSON, W. D., SCHAR, M., TANG, L., KRAITCHMAN,
D. L., BOSTON, R. C., SOSNOVIK, D. E., WEISS, R. G., WEISSLEDER, R. & STUBER, M. (2008)
Off-resonance angiography: a new method to depict vessels - phantom and rabbit
studies. Radiology , 249 , 501-9.
KWON, I. K. & MATSUDA, T. (2005) Co-electrospun nanofi ber fabrics of poly(L-lactide-
co-epsilon-caprolactone) with type I collagen or heparin. Biomacromolecules , 6 ,
2096-105.
LANGEREIS, S., DE LUSSANET, Q. G., VAN GENDEREN, M. H., MEIJER, E. W., BEETS-TAN, R. G.,
GRIFFI OEN, A. W., VAN ENGELSHOVEN, J. M. & BACKES, W. H. (2006) Evaluation of
Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents
for MR imaging. NMR Biomed , 19 , 133-41.
LANZA, G. M., YU, X., WINTER, P. M., ABENDSCHEIN, D. R., KARUKSTIS, K. K., SCOTT, M. J.,
CHINEN, L. K., FUHRHOP, R. W., SCHERRER, D. E. & WICKLINE, S. A. (2002) Targeted
antiproliferative drug delivery to vascular smooth muscle cells with a magnetic
resonance imaging nanoparticle contrast agent: implications for rational therapy
of restenosis. Circulation , 106 , 2842-7.
LARSON, D. R., ZIPFEL, W. R., WILLIAMS, R. M., CLARK, S. W., BRUCHEZ, M. P., WISE, F. W. &
WEBB, W. W. (2003) Water-soluble quantum dots for multiphoton fl uorescence
imaging in vivo . Science , 300 , 1434-6.
LEWIS, J. D., DESTITO, G., ZIJLSTRA, A., GONZALEZ, M. J., QUIGLEY, J. P., MANCHESTER, M.
& STUHLMANN, H. (2006) Viral nanoparticles as tools for intravital vascular imaging.
Nat Med , 12 , 354-60.
LIAPIS, C. D., AVGERINOS, E. D., KADOGLOU, N. P. & KAKISIS, J. D. (2009) What a vascular
surgeon should know and do about atherosclerotic risk factors. J Vasc Surg , 49 ,
1348-54.
LIM, H. J., NAM, H. Y., LEE, B. H., KIM, D. J., KO, J. Y. & PARK, J. S. (2007) A novel technique
for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Bio-
technol Prog , 23 , 693-7.
MA, Z., HE, W., YONG, T. & RAMAKRISHNA, S. (2005) Grafting of gelatin on electrospun
poly(caprolactone) nanofi bers to improve endothelial cell spreading and prolif-
eration and to control cell orientation. Tissue Eng , 11 , 1149-58.
MAHAPATRO, A., JOHNSON, D. M., PATEL, D. N., FELDMAN, M. D., AYON, A. A. & AGRAWAL,
C. M. (2006) The use of alkanethiol self-assembled monolayers on 316L stainless
steel for coronary artery stent nanomedicine applications: an oxidative and in
vitro stability study. Nanomedicine , 2 , 182-90.
MARGOLIS, J., MCDONALD, J., HEUSER, R., KLINKE, P., WAKSMAN, R., VIRMANI, R., DESAI, N.
& HILTON, D. (2007) Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent
restenosis I (SNAPIST-I): a fi rst-in-human safety and dose-fi nding study. Clin
Cardiol , 30 , 165-70.
MATSUSAKI, M., SAKAGUCHI, H., SERIZAWA, T. & AKASHI, M. (2007) Controlled release
of vascular endothelial growth factor from alginate hydrogels nano-coated with
polyelectrolyte multilayer fi lms. J Biomater Sci Polym Ed , 18 , 775-83.
MEI, L., SUN, H., JIN, X., ZHU, D., SUN, R., ZHANG, M. & SONG, C. (2007) Modifi ed pacli-
taxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon
injury model. Pharm Res , 24 , 955-62.

￿ ￿ ￿ ￿ ￿